1. Home
  2. BLMN vs OCUL Comparison

BLMN vs OCUL Comparison

Compare BLMN & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BLMN

Bloomin' Brands Inc.

HOLD

Current Price

$6.58

Market Cap

569.7M

ML Signal

HOLD

Logo Ocular Therapeutix Inc.

OCUL

Ocular Therapeutix Inc.

HOLD

Current Price

$9.17

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLMN
OCUL
Founded
1988
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
569.7M
2.2B
IPO Year
2012
2014

Fundamental Metrics

Financial Performance
Metric
BLMN
OCUL
Price
$6.58
$9.17
Analyst Decision
Hold
Strong Buy
Analyst Count
8
10
Target Price
$8.50
$22.56
AVG Volume (30 Days)
2.1M
5.7M
Earning Date
02-25-2026
02-05-2026
Dividend Yield
7.00%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,952,793,000.00
$55,783,000.00
Revenue This Year
$2.19
N/A
Revenue Next Year
$0.35
$11.96
P/E Ratio
N/A
N/A
Revenue Growth
7.72
N/A
52 Week Low
$5.86
$5.79
52 Week High
$12.70
$16.44

Technical Indicators

Market Signals
Indicator
BLMN
OCUL
Relative Strength Index (RSI) 46.65 33.08
Support Level $7.30 $8.36
Resistance Level $6.86 $11.13
Average True Range (ATR) 0.40 0.72
MACD -0.10 -0.17
Stochastic Oscillator 31.25 18.97

Price Performance

Historical Comparison
BLMN
OCUL

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabba's. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S., while restaurants operating outside the U.S. are included in the international segment.

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Share on Social Networks: